<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Anticancer activity of a new gonadotropin releasing hormone analogue</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Wiley</publisher>
				<availability status="unknown"><p>Copyright Wiley</p>
				</availability>
				<date type="published" when="2009-11-11">2009-11-11</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mohammad</forename><forename type="middle">Mirzaei</forename><surname>Saleh-Abady</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Biophysics</orgName>
								<orgName type="department" key="dep2">School of Basic Science</orgName>
								<orgName type="institution">Tarbiat Modares University</orgName>
								<address>
									<settlement>Tehran</settlement>
									<country key="IR">Iran</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>Ph.D</roleName><forename type="first">Hossein</forename><surname>Naderi-Manesh</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Biophysics</orgName>
								<orgName type="department" key="dep2">School of Basic Science</orgName>
								<orgName type="institution">Tarbiat Modares University</orgName>
								<address>
									<settlement>Tehran</settlement>
									<country key="IR">Iran</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Abdolali</forename><surname>Alizadeh</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Organic Chemistry</orgName>
								<orgName type="department" key="dep2">School of Basic Science</orgName>
								<orgName type="institution">Tarbiat Modares University</orgName>
								<address>
									<settlement>Tehran</settlement>
									<country key="IR">Iran</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fereshteh</forename><surname>Shamsipour</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution" key="instit1">Monoclonal Antibody Research Center</orgName>
								<orgName type="institution" key="instit2">Avicenna Research Institute</orgName>
								<orgName type="institution" key="instit3">ACECR</orgName>
								<address>
									<settlement>Tehran</settlement>
									<country key="IR">Iran</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Saeed</forename><surname>Balalaie</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Armin</forename><surname>Arabanian</surname></persName>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Department of Biophysics</orgName>
								<orgName type="department" key="dep2">School of Basic Science</orgName>
								<orgName type="institution">Tarbiat Modares University</orgName>
								<address>
									<settlement>Tehran</settlement>
									<country key="IR">Iran</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Anticancer activity of a new gonadotropin releasing hormone analogue</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Biopolymers</title>
						<title level="j" type="abbrev">Biopolymers</title>
						<idno type="ISSN">0006-3525</idno>
						<imprint>
							<publisher>Wiley</publisher>
							<biblScope unit="volume">94</biblScope>
							<biblScope unit="issue">3</biblScope>
							<biblScope unit="page" from="292" to="297"/>
							<date type="published" when="2009-11-11" />
						</imprint>
					</monogr>
					<idno type="DOI">10.1002/bip.21335</idno>
					<idno type="PMID">19908246</idno>
					<idno type="ark">ark:/67375/WNG-PQPDP67K-4</idno>
					<idno type="istexId">F24D4AF69E414A902099C9B5BBFACF72B195A2BE</idno>
					<note type="submission">Received: 26 Jul 2009 Accepted: 13 Sep 2009</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T23:16+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Anticancer activity</term>
					<term>Breast cancer</term>
					<term>LHRH analogue</term>
					<term>Ovarian cancer</term>
					<term>Peptidomimetics</term>
					<term>Triptorelin</term>
				</keywords>
			</textClass>
			<abstract>
				<p>Gonadotropin releasing hormone (GnRH) plays a key role in reproduction. This decapeptide is synthesized and released by hypothalamus and induces the pituitary gonadotrop cells to release pituitary gonadotropin hormones. In some extrapituitary compartments GnRH and its receptor act as part of the autocrine regulatory system of cell proliferation. The anticancer activity of GnRH and its analogues has been observed by many researchers. In this study the anticancer activity of a new analogue of GnRH and triptorelin was investigated by cell proliferation assay. Results indicate that proliferation of human breast and ovarian cancer cell lines are dose-dependently inhibited. The inhibitory efficiency of the new analogue is proved to be higher than the original triptorelin. In addition to its antimitogenic activity, evidence was found for the involvement of the apoptotic mechanism in the action of the new analogue and triptorelin. In conclusion, the new analogue can be considered as a good pharmaceutical candidate.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>Gonadotropin releasing hormone (GnRH) is the central regulator of the reproductive hormonal cascade. This decapeptide is synthesized and released by hypothalamic secretory neuron which is delivered to the pituitary gland via hypophyseal portal blood system. Interaction of GnRH with its receptors on the pituitary gonadotrop cells induces the release of pituitary gonadotropin hormones, which in turn regulate gonadal steroidogenesis and gametogenesis in both sexes <ref type="bibr" target="#b0">(1)</ref> . Therefore, GnRH analogues have been used in the assisted reproduction (in vitro fertilization and embryo transfer), treatment of infertility due to polycystic ovarian diseases and fibroids. Also the efficiency of analogues of GnRH for the treatment of children with precocious puberty, endometrial carcinoma, estrogen-dependent breast cancer and prostate cancer is well established <ref type="bibr" target="#b1">(2)</ref> . There is growing evidence of autocrine/ paracrine GnRH systems in human reproductive tissues <ref type="bibr" target="#b2">(3)</ref><ref type="bibr" target="#b3">(4)</ref><ref type="bibr" target="#b4">(5)</ref><ref type="bibr" target="#b5">(6)</ref> . Recent studies suggest that about 50% of breast cancer and 80% of ovarian cancer cell lines express highaffinity binding site for GnRH and its analogues as part of the autocrine regulatory system of cell proliferation. Therefore anticancer activity of GnRH analogues has been observed by many others <ref type="bibr" target="#b6">(7)</ref><ref type="bibr" target="#b7">(8)</ref><ref type="bibr" target="#b8">(9)</ref><ref type="bibr" target="#b9">(10)</ref><ref type="bibr" target="#b10">(11)</ref> .</p><p>Since 1972 systematic work has been preceding to synthesize agonistic and antagonistic analogues of GnRH. A powerful interest in medical applications of GnRH derivatives stimulated this undertaking. Thus, the intense activity that has occurred in this field was caused by the desire to synthesize super active analogue with prolonged biologic activity. Many agonistic and antagonistic analogues more potent than the parent hormone have been made. Several of these analogues such as triptorelin, goserelin, leuprorelin and buserelin are being used clinically and the list of their applications is steadily expanding <ref type="bibr" target="#b1">(2)</ref> .</p><p>Considerable effort has been devoted to the synthesis of peptidomimetic structures to overcome the unfavorable properties and a therapeutic deficiency of peptides <ref type="bibr" target="#b11">(12,</ref><ref type="bibr" target="#b12">13)</ref> . Among them is insertion of some chemical groups in the peptide sequences to increase their activity efficiency. In the present work the anticancer activity of a new GnRH analogue was investigated in comparison with triptorelin. The new analogue structure is similar to triptorelin with two extra chemical groups inserted between Leu7 and Arg8 in order to increase peptide hydrophobic properties ( <ref type="figure" target="#fig_0">Figure 1</ref>). Based on previous report on the molecular mechanism of ligand interaction with the GnRH receptor <ref type="bibr" target="#b13">(14)</ref> , the hydrogen bonding and Ï€-stacking interaction play main roles in GnRH and its receptor interaction. Therefore we expect stronger interaction between new analogue and GnRH receptor leading to greater peptide activity.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Material</head><p>[D-Trp 6 ] LHRH (Triptorelin) was synthesized in our laboratory by solid phase method and the new analogue was kindly provided by Dr Balalaie et al <ref type="bibr" target="#b14">(15)</ref> . Human breast cancer cell line (T47D) and ovarian cancer cell line (OVCAR3) were obtained from Pasteur Institute of Iran. RPMI 1640 and Fetal Bovine Serum (FBS) were purchased from Gibco (USA) and Biosera (UK). Multiple 6 welldishes were Greiner bio-one (Germany) product. Annexin V-FITC apoptosis detection kit was obtained from BD Bioscience, Pharmingen (US).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell culture</head><p>Human breast cancer cell line (T47D) and ovarian cancer cell line (OVCAR3) were maintained in RPMI 1640 medium supplemented with 10% heat-inactivated bovine serum albumin and kept at 37 Â°C in a humidified 5% CO 2 atmosphere.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell proliferation assay</head><p>To determine the anti-proliferation activity of the new analogue, the dose-dependent proliferation experiments were performed. In brief following steps were carried out: 2Ã—10 <ref type="bibr" target="#b3">4</ref> cells of each cell line were plated in multiple 6 well-dishes. After 24 hr, the cells were treated with 10 -11 , 10 -9 , 10 -7 and 10 -5 M concentrations of each peptide. This treatment was repeated three times during six days. On the six th day, cells were trypsinized and after Trypan-blue staining, the viable cells were counted with Neubauer-type hemocytometer and the data was expressed as the percentage of control. All proliferation assays were performed at least three times.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Apoptotic assay</head><p>Cytomorphological changes were observed only in treated OVCAR3 cells in 10 -9 M concentration of triptorelin with an Olympus phase-contrast microscope. Cell death by apoptosis was confirmed using Annexin V-FITC apoptosis detection kit with a vital dye such as Propidium-Iodide (PI) according to the manufacturerâ€²s instructions. Briefly, OVCAR3 adherent cells that were treated with triptorelin and the new analogue were washed with the culture medium. Surface exposure of Phosphatidyl Serine (PS), as a plasma membrane asymmetry in apoptotic cells, was detected by adding annexin V-FITC to the culture medium in a final concentration of 5 Î¼g/ml. The cells incubated for 5 min at room temperature, then PI was added (1 Î¼g/ml) <ref type="bibr" target="#b15">(16,</ref><ref type="bibr" target="#b16">17)</ref> . After rinsing with culture medium to remove excess dyes, the cells were observed by fluorescence microscope (Olympus).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p>The data from three or four dose-dependent experiments were tested by ANOVA followed by post-hoc analysis (Duncan test). All analysis performed with SPSS software.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p>In T47D and OVCAR3 cell lines, proliferation was dose-dependently inhibited with different concentrations (10 -11 , 10 -9 , 10 -7 and 10 -5 M) of the new analogue and triptorelin <ref type="figure">(Figures 2 and 3)</ref>. The anticancer activity of the new analogue was higher than triptorelin at all concentrations. <ref type="table">Table 1</ref> gives a comparison of the cell number percent of cancer cell lines after treatment with triptorelin and the new analogue.</p><p>After treatment of OVCAR3 cell line with the new analogue and triptorelin, some morphologic signs of programmed cell death could be detected by invert phase contrast microscope. The vacuoles in the cytoplasm, rounding-up of cells, apoptotic bodies and bleb formation were seen as characteristic signs of the apoptotic process, while control cells had normal morphology <ref type="figure" target="#fig_2">(Figure 4</ref>). Apoptosis was also confirmed by annexin V-FITC apoptosis detection kit. OVCAR3 cells with annexinV -/PIwere alive, annexin V + /PIwere undergoing early apoptosis and annexinV + /PI + were either in the end of apoptosis or were dead ( <ref type="figure" target="#fig_3">Figure 5</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>The anticancer activity of the new analogue  10 -11 10 -9 10 -7 10 -5</p><p>Cell lines was higher than triptorelin at different concentrations. The improved activity of the new analogue is probably due to its stronger interaction with the GnRH receptor. SÃ¶derhÃ¤ll et al reported that the insertion of hydrophobic groups in GnRH sequence would increase the Ï€-stacking interaction of the peptide with the hydrophobic pocket of GnRH receptor and therefore improved its activity <ref type="bibr" target="#b17">(18)</ref> . Furthermore the presence of such chemical groups in the new analogue sequence is thought to increase the protease stability of the new analogue and therefore increase its biological activity.</p><p>The results of our proliferation assay correspond to similar observations obtained by other groups and are explained by the fact that GnRH and its receptor are parts of the negative autocrine regulatory system of cell proliferation <ref type="bibr" target="#b6">(7)</ref><ref type="bibr" target="#b7">(8)</ref><ref type="bibr" target="#b8">(9)</ref><ref type="bibr" target="#b9">(10)</ref> . The most important features of GnRH signaling in tumors are the inhibitory interference with mitogenic pathway that results in antiproliferative actions. This peptide activates a protein tyrosine phosphatase that could inhibit the mitogenic signal transduction of growth factor receptors and therefore down regulates the cell proliferation <ref type="bibr" target="#b9">(10)</ref> . In another way our findings support previous studies that some GnRH analogues can prompt apoptosis in breast, ovarian, endometrium and prostate cancer cell lines <ref type="bibr" target="#b0">(1,</ref><ref type="bibr" target="#b18">(19)</ref><ref type="bibr" target="#b19">(20)</ref><ref type="bibr" target="#b20">(21)</ref><ref type="bibr" target="#b21">(22)</ref><ref type="bibr" target="#b22">(23)</ref><ref type="bibr" target="#b24">(24)</ref><ref type="bibr" target="#b25">(25)</ref><ref type="bibr" target="#b26">(26)</ref><ref type="bibr" target="#b27">(27)</ref><ref type="bibr" target="#b28">(28)</ref> . However the mechanism underlying the apoptotic effect of the analogues in the human counterpart is not fully known.</p><p>In conclusion our results show that the anticancer activity of the new analogue is more than triptorelin and it seems to be due to the known mechanisms of GnRH effect on extrapituitary compartments that was explained before. Therefore this new analogue can be considered as a good pharmaceutical candidate.  </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc>Chemical structures of the triptorelin and the new analogue</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 3 .Figure 2 .</head><label>32</label><figDesc>Effect of 6 days of treatment with different concentrations of triptorelin and the new analogue on OVCAR3 cell line. Each column represents the cell number percent in comparison with control. The data are representative of three independent experiments. Analysis of variance: P&lt; 0.01 Effect of 6 days of treatment with different concentrations of triptorelin and the new analogue on T47D cell line. Each column represents the cell number percent in comparison with the control. The data are representative of three independent experiments. Analysis of variance: P&lt;0.01 Table 1. Cell number percent of cancer cell lines after treatment with (10 -11 , 10 -9 , 10 -7 , and 10 -5 M) concentration of triptorelin and the new analogue Cells, % of control Triptorelin (M) New analogue (M) 10 -11 10 -9 10 -7 10 -5</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 4 .</head><label>4</label><figDesc>(a) Normal OVCAR3 cell line. (b)Apoptotic forms of OVCAR3 cell line observed by invert phase-contrast microscope. Arrows show the morphologic signs of programmed cell death in early apoptosis</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 5 .</head><label>5</label><figDesc>Apoptotic forms of OVCAR3 cell line observed by fluorescence microscope. OVCAR3 cell line was stained with annexinV-FITC/PI. Arrows show the plasma membrane asymmetry in early apoptotic cells. Boxes show different stage of apoptosis such as early and late / already dead cells</figDesc></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgement</head><p>We appreciate the helpful discussion and comments given by Dr. Sadjady. The authors also express their gratitude to the Research Council of Tarbiat Modares University.</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Gonadotropin-Releasing Hormone (GnRH) Antagonists Promote Proapoptotic Signaling in Peripheral Reproductive Tumor Cells by Activating a GÎ±i-Coupling State of the Type I GnRH Receptor</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stuart</forename><surname>Maudsley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lindsay</forename><surname>Davidson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Adam</forename><forename type="middle">J</forename><surname>Pawson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Raymond</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rakel</forename><forename type="middle">LÃ³pez</forename><surname>De Maturana</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">P</forename><surname>Millar</surname></persName>
		</author>
		<idno type="DOI">10.1158/0008-5472.can-04-1360</idno>
		<idno type="PMID">15492280</idno>
		<ptr type="open-access" target="http://cancerres.aacrjournals.org/content/64/20/7533.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<title level="j" type="abbrev">Cancer Res</title>
		<idno type="ISSN">0008-5472</idno>
		<idno type="ISSNe">1538-7445</idno>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="issue">20</biblScope>
			<biblScope unit="page" from="7533" to="7544" />
			<date type="published" when="2004-10-15" />
			<publisher>American Association for Cancer Research (AACR)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Luteinizing hormone-releasing hormone analogs: their impact on the control of tumorigenesisâ˜†</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">V</forename><surname>Schally</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0196-9781(99)00130-8</idno>
		<idno type="PMID">10573298</idno>
		<idno type="PII">S0196-9781(99)00130-8</idno>
		<idno type="ark">ark:/67375/6H6-3WWFTKR1-T</idno>
		<idno type="istexId">C292A426048E4356D7A2D0DFDFA46558D6A30632</idno>
	</analytic>
	<monogr>
		<title level="j">Peptides</title>
		<title level="j" type="abbrev">Peptides</title>
		<idno type="ISSN">0196-9781</idno>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1247" to="1262" />
			<date type="published" when="1999-10" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Characterization of cDNA for precursor of human luteinizing hormone releasing hormone</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><forename type="middle">H</forename><surname>Seeburg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">P</forename><surname>Adelman</surname></persName>
		</author>
		<idno type="DOI">10.1038/311666a0</idno>
		<idno type="PMID">6090951</idno>
		<idno type="ark">ark:/67375/GT4-ZNVSM2LS-W</idno>
		<idno type="istexId">3A171A3C6AA689A61DDE82C1F92D9C89D3419DF2</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<title level="j" type="abbrev">Nature</title>
		<idno type="ISSN">0028-0836</idno>
		<idno type="ISSNe">1476-4687</idno>
		<imprint>
			<biblScope unit="volume">311</biblScope>
			<biblScope unit="issue">5987</biblScope>
			<biblScope unit="page" from="666" to="668" />
			<date type="published" when="1984-10" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Expression of Gonadotropin-Releasing Hormone and Prothymosin-Î± Messenger Ribonucleic Acid in the Ovary*</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mamoru</forename><surname>Oikawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Cathy</forename><surname>Dargan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tor</forename><surname>Ny</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Aaron</forename><forename type="middle">J W</forename><surname>Hsueh</surname></persName>
		</author>
		<idno type="DOI">10.1210/endo-127-5-2350</idno>
		<idno type="PMID">2226321</idno>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<title level="j" type="abbrev">Endocrinology</title>
		<idno type="ISSN">0013-7227</idno>
		<idno type="ISSNe">1945-7170</idno>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="2350" to="2356" />
			<date type="published" when="1990-11" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">The gene for the neuropeptide gonadotropin-releasing hormone is expressed in the mammary gland of lactating rats.</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Palmon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Ben Aroya</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Tel-Or</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Burstein</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Fridkin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Koch</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.91.11.4994</idno>
		<idno type="PMID">8197170</idno>
		<idno type="PMCID">PMC43916</idno>
		<ptr type="open-access" target="http://www.pnas.org/content/91/11/4994.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences</title>
		<title level="j" type="abbrev">Proceedings of the National Academy of Sciences</title>
		<idno type="ISSN">0027-8424</idno>
		<idno type="ISSNe">1091-6490</idno>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="4994" to="4996" />
			<date type="published" when="1994-05-24" />
			<publisher>Proceedings of the National Academy of Sciences</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">PRESENCE OF LUTEINIZING HORMONE-RELEASING HORMONE (LHRH) mRNA IN RAT SPLEEN LYMPHOCYTES</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nasrin</forename><surname>Azad</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nicholas</forename><forename type="middle">V</forename><surname>Emanuele</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Margaret</forename><forename type="middle">M</forename><surname>Halloran</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><surname>Tentler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><forename type="middle">R</forename><surname>Kelley</surname></persName>
		</author>
		<idno type="DOI">10.1210/endo-128-3-1679</idno>
		<idno type="PMID">1999181</idno>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<title level="j" type="abbrev">Endocrinology</title>
		<idno type="ISSN">0013-7227</idno>
		<idno type="ISSNe">1945-7170</idno>
		<imprint>
			<biblScope unit="volume">128</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="1679" to="1681" />
			<date type="published" when="1991-03" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Emons</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>SchrÃ¶der</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Ortmann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Westphalen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Schulz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">V</forename><surname>Schally</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.77.6.1458</idno>
		<idno type="PMID">8263128</idno>
		<ptr type="open-access" target="http://cancerres.aacrjournals.org/content/53/22/5439.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Endocrinology &amp; Metabolism</title>
		<title level="j" type="abbrev">Journal of Clinical Endocrinology &amp; Metabolism</title>
		<idno type="ISSN">0021-972X</idno>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1458" to="1464" />
			<date type="published" when="1993-12-01" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Biology of the gonadotropin-releasing hormone system in gynecological cancers</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Grundker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Gunthert</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Westphalen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Emons</surname></persName>
		</author>
		<idno type="DOI">10.1530/eje.0.1460001</idno>
		<idno type="PMID">11751060</idno>
		<ptr type="open-access" target="https://eje.bioscientifica.com/downloadpdf/journals/eje/146/1/1.pdf" />
	</analytic>
	<monogr>
		<title level="j">European Journal of Endocrinology</title>
		<title level="j" type="abbrev">European Journal of Endocrinology</title>
		<idno type="ISSN">0804-4643</idno>
		<idno type="ISSNe">1479-683X</idno>
		<imprint>
			<biblScope unit="volume">146</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="14" />
			<date type="published" when="2002-01-01" />
			<publisher>Bioscientifica</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Expression of receptors for luteinizing hormone-releasing hormone in human ovarian and endometrial cancers: Frequency, autoregulation, and correlation with direct antiproliferative activity of luteinizing hormone-releasing hormone analogues</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><surname>VÃ¶lker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carsten</forename><surname>GrÃ¼ndker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Oswald</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Klaus-Dieter</forename><surname>Schulz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">GÃ¼nter</forename><surname>Emons</surname></persName>
		</author>
		<idno type="DOI">10.1067/mob.2002.119633</idno>
		<idno type="PMID">11854630</idno>
	</analytic>
	<monogr>
		<title level="j">American Journal of Obstetrics and Gynecology</title>
		<title level="j" type="abbrev">American Journal of Obstetrics and Gynecology</title>
		<idno type="ISSN">0002-9378</idno>
		<imprint>
			<biblScope unit="volume">186</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="171" to="179" />
			<date type="published" when="2002-02" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">GnRH antagonists in the treatment of gynecological and breast cancers</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Emons</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Grundker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">R</forename><surname>Gunthert</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Westphalen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Kavanagh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Verschraegen</surname></persName>
		</author>
		<idno type="DOI">10.1677/erc.0.0100291</idno>
		<idno type="PMID">12790790</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/23b3/4330c203fc570e0a869bedfdd44f5e4804eb.pdf" />
	</analytic>
	<monogr>
		<title level="j">Endocrine Related Cancer</title>
		<title level="j" type="abbrev">Endocrine Related Cancer</title>
		<idno type="ISSN">1351-0088</idno>
		<idno type="ISSNe">1479-6821</idno>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="291" to="299" />
			<date type="published" when="2003-06-01" />
			<publisher>Bioscientifica</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Structureâ€“activity study on the LH- and FSH-releasing and anticancer effects of gonadotropin-releasing hormone (GnRH)-III analogs</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Magdolna</forename><surname>KovÃ¡cs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">BorbÃ¡la</forename><surname>Vincze</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Judit</forename><forename type="middle">E</forename><surname>HorvÃ¡th</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">JÃ¡nos</forename><surname>SeprÅ‘di</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.peptides.2007.01.003</idno>
		<idno type="PMID">17289216</idno>
	</analytic>
	<monogr>
		<title level="j">Peptides</title>
		<title level="j" type="abbrev">Peptides</title>
		<idno type="ISSN">0196-9781</idno>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="821" to="829" />
			<date type="published" when="2007-04" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Nonpeptidic ligands for peptide and protein receptors</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roger</forename><forename type="middle">M</forename><surname>Freidinger</surname></persName>
		</author>
		<idno type="DOI">10.1016/s1367-5931(99)80060-x</idno>
		<idno type="PMID">10419845</idno>
		<idno type="PII">S1367-5931(99)80060-X</idno>
		<idno type="ark">ark:/67375/6H6-7Q83R3ZB-S</idno>
		<idno type="istexId">4B0DA66D334460C489BA3DBAC3582F7CFE1A3C80</idno>
	</analytic>
	<monogr>
		<title level="j">Current Opinion in Chemical Biology</title>
		<title level="j" type="abbrev">Current Opinion in Chemical Biology</title>
		<idno type="ISSN">1367-5931</idno>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="395" to="406" />
			<date type="published" when="1999-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<monogr>
		<title level="m" type="main">Synthesis of peptide and peptidomimetics. E22C</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Goodman</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2004" />
			<pubPlace>Stuttgart: Thieme</pubPlace>
		</imprint>
	</monogr>
	<note>1st ed</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Molecular Mechanisms of Ligand Interaction with the Gonadotropin-Releasing Hormone Receptor</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stuart</forename><forename type="middle">C</forename><surname>Sealfon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Harel</forename><surname>Weinstein</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">P</forename><surname>Millar</surname></persName>
		</author>
		<idno type="DOI">10.1210/edrv.18.2.0295</idno>
		<idno type="PMID">9101136</idno>
		<ptr type="open-access" target="https://academic.oup.com/edrv/article-pdf/18/2/180/8859344/edrv0180.pdf" />
	</analytic>
	<monogr>
		<title level="j">Endocrine Reviews</title>
		<title level="j" type="abbrev">Endocrine Reviews</title>
		<idno type="ISSN">0163-769X</idno>
		<idno type="ISSNe">1945-7189</idno>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="180" to="205" />
			<date type="published" when="1997-04" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Synthesis of novel Gn-RH analogues using Ugi-4MCR</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Armin</forename><surname>Arabanian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mahdieh</forename><surname>Mohammadnejad</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Saeed</forename><surname>Balalaie</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">JÃ¼rgen</forename><forename type="middle">H</forename><surname>Gross</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bmcl.2008.11.111</idno>
		<idno type="PMID">19103486</idno>
	</analytic>
	<monogr>
		<title level="j">Bioorganic &amp; Medicinal Chemistry Letters</title>
		<title level="j" type="abbrev">Bioorganic &amp; Medicinal Chemistry Letters</title>
		<idno type="ISSN">0960-894X</idno>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="887" to="890" />
			<date type="published" when="2009-02" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Manon</forename><surname>Van Engeland</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Frans</forename><forename type="middle">C S</forename><surname>Ramaekers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bert</forename><surname>Schutte</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chris</forename><forename type="middle">P M</forename><surname>Reutelingsperger</surname></persName>
		</author>
		<idno type="DOI">10.1002/(sici)1097-0320(19960601)24:2&lt;131::aid-cyto5&gt;3.0.co;2-m</idno>
		<idno type="PMID">8725662</idno>
	</analytic>
	<monogr>
		<title level="j">Cytometry</title>
		<title level="j" type="abbrev">Cytometry</title>
		<idno type="ISSN">0196-4763</idno>
		<idno type="ISSNe">1097-0320</idno>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="131" to="139" />
			<date type="published" when="1996-06-01" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus.</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Casciola-Rosen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Rosen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Petri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Schlissel</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.93.4.1624</idno>
		<idno type="PMID">8643681</idno>
		<idno type="PMCID">PMC39992</idno>
		<ptr type="open-access" target="http://www.pnas.org/content/93/4/1624.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences</title>
		<title level="j" type="abbrev">Proceedings of the National Academy of Sciences</title>
		<idno type="ISSN">0027-8424</idno>
		<idno type="ISSNe">1091-6490</idno>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1624" to="1629" />
			<date type="published" when="1996-02-20" />
			<publisher>Proceedings of the National Academy of Sciences</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Antagonist and agonist binding models of the human gonadotropin-releasing hormone receptor</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">Arvid</forename><surname>SÃ¶derhÃ¤ll</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Emmanuel</forename><forename type="middle">E</forename><surname>Polymeropoulos</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Klaus</forename><surname>Paulini</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eckhard</forename><surname>GÃ¼nther</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ronald</forename><surname>KÃ¼hne</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bbrc.2005.05.142</idno>
		<idno type="PMID">15950933</idno>
	</analytic>
	<monogr>
		<title level="j">Biochemical and Biophysical Research Communications</title>
		<title level="j" type="abbrev">Biochemical and Biophysical Research Communications</title>
		<idno type="ISSN">0006-291X</idno>
		<imprint>
			<biblScope unit="volume">333</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="568" to="582" />
			<date type="published" when="2005-07" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Gonadotropin-releasing hormone analogue conjugates with strong selective antitumor activity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Palyi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Vincze</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Lovas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Mezo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Pato</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Kalnay</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Turi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Gaal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Mihalik</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Peter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Teplan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">F</forename><surname>Murphy</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.96.5.2361</idno>
		<idno type="PMID">10051647</idno>
		<idno type="PMCID">PMC26789</idno>
		<ptr type="open-access" target="http://www.pnas.org/content/96/5/2361.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences</title>
		<title level="j" type="abbrev">Proceedings of the National Academy of Sciences</title>
		<idno type="ISSN">0027-8424</idno>
		<idno type="ISSNe">1091-6490</idno>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="2361" to="2366" />
			<date type="published" when="1999-03-02" />
			<publisher>Proceedings of the National Academy of Sciences</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Gonadotropin-Releasing Hormone Type II Antagonists Induce Apoptotic Cell Death in Human Endometrial and Ovarian Cancer Cells In vitro and In vivo</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Fister</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">R</forename><surname>Gunthert</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Emons</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Grundker</surname></persName>
		</author>
		<idno type="DOI">10.1158/0008-5472.can-06-3222</idno>
		<idno type="PMID">17308117</idno>
		<ptr type="open-access" target="http://cancerres.aacrjournals.org/content/67/4/1750.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<title level="j" type="abbrev">Cancer Research</title>
		<idno type="ISSN">0008-5472</idno>
		<idno type="ISSNe">1538-7445</idno>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1750" to="1756" />
			<date type="published" when="2007-02-15" />
			<publisher>American Association for Cancer Research (AACR)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Expression of Gonadotropin-Releasing Hormone II (GnRH-II) Receptor in Human Endometrial and Ovarian Cancer Cells and Effects of GnRH-II on Tumor Cell Proliferation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carsten</forename><surname>GrÃ¼ndker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andreas</forename><forename type="middle">R</forename><surname>GÃ¼nthert</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">P</forename><surname>Millar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">GÃ¼nter</forename><surname>Emons</surname></persName>
		</author>
		<idno type="DOI">10.1210/jcem.87.3.8437</idno>
		<idno type="PMID">11889221</idno>
		<ptr type="open-access" target="https://academic.oup.com/jcem/article-pdf/87/3/1427/9160001/jcem1427.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<title level="j" type="abbrev">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<idno type="ISSN">0021-972X</idno>
		<idno type="ISSNe">1945-7197</idno>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="1427" to="1430" />
			<date type="published" when="2002-03" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Differential Effects of Gonadotropin-Releasing Hormone (GnRH)-I and GnRH-II on Prostate Cancer Cell Signaling and Death</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kaushik</forename><surname>Maiti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Da</forename><forename type="middle">Young</forename><surname>Oh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jung</forename><forename type="middle">Sun</forename><surname>Moon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sujata</forename><surname>Acharjee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jian</forename><forename type="middle">Hua</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dong</forename><forename type="middle">Gyu</forename><surname>Bai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hee-Sae</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Keesook</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Young</forename><forename type="middle">Chul</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Neon</forename><forename type="middle">Chul</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kyungjin</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hubert</forename><surname>Vaudry</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hyuk</forename><forename type="middle">Bang</forename><surname>Kwon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jae</forename><forename type="middle">Young</forename><surname>Seong</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.2004-1894</idno>
		<idno type="PMID">15870130</idno>
		<ptr type="open-access" target="https://academic.oup.com/jcem/article-pdf/90/7/4287/10776555/jcem4287.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<title level="j" type="abbrev">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<idno type="ISSN">0021-972X</idno>
		<idno type="ISSNe">1945-7197</idno>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="4287" to="4298" />
			<date type="published" when="2005-07" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Molecular Biology of Gonadotropin-Releasing Hormone (GnRH)-I, GnRH-II, and Their Receptors in Humans</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chi</forename><forename type="middle">Keung</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><forename type="middle">C K</forename><surname>Leung</surname></persName>
		</author>
		<idno type="DOI">10.1210/er.2003-0039</idno>
		<idno type="PMID">15561800</idno>
		<ptr type="open-access" target="https://academic.oup.com/edrv/article-pdf/26/2/283/8862113/edrv0283.pdf" />
	</analytic>
	<monogr>
		<title level="j">Endocrine Reviews</title>
		<title level="j" type="abbrev">Endocrine Reviews</title>
		<idno type="ISSN">0163-769X</idno>
		<idno type="ISSNe">1945-7189</idno>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="283" to="306" />
			<date type="published" when="2005-04" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">GnRH-II, and their receptors in humans</title>
	</analytic>
	<monogr>
		<title level="j">Endocr Rev</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="283" to="306" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Gonadotropin-releasing hormone agonist induces apoptosis and reduces cell proliferation in eutopic endometrial cultures from women with endometriosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gabriela</forename><forename type="middle">F</forename><surname>Meresman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mariela</forename><surname>Bilotas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ricardo</forename><forename type="middle">A</forename><surname>Buquet</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rosa</forename><forename type="middle">I</forename><surname>BaraÃ±ao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carlos</forename><surname>Sueldo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marta</forename><surname>Tesone</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0015-0282(03)00769-6</idno>
		<idno type="PMID">14505742</idno>
	</analytic>
	<monogr>
		<title level="j">Fertility and Sterility</title>
		<title level="j" type="abbrev">Fertility and Sterility</title>
		<idno type="ISSN">0015-0282</idno>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="702" to="707" />
			<date type="published" when="2003-09" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Gonadotropin-releasing hormone directly induces apoptotic cell death in the rat ovary: biochemical and in situ detection of deoxyribonucleic acid fragmentation in granulosa cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Billig</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Furuta</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">J</forename><surname>Hsueh</surname></persName>
		</author>
		<idno type="DOI">10.1210/en.134.1.245</idno>
		<idno type="PMID">8275940</idno>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<title level="j" type="abbrev">Endocrinology</title>
		<idno type="ISSN">0013-7227</idno>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="245" to="252" />
			<date type="published" when="1994-01-01" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Effect of Luteinizing Hormone-Releasing Hormone Analogs on the Rat Ovarian Follicle Development</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tetsu</forename><surname>Yano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Naomi</forename><surname>Yano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hirotaka</forename><surname>Matsumi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yutaka</forename><surname>Morita</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Osamu</forename><surname>Tsutsumi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">V</forename><surname>Schally</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuji</forename><surname>Taketani</surname></persName>
		</author>
		<idno type="DOI">10.1159/000191298</idno>
		<idno type="PMID">9267814</idno>
	</analytic>
	<monogr>
		<title level="j">Hormone Research</title>
		<title level="j" type="abbrev">Horm Res</title>
		<idno type="ISSN">0301-0163</idno>
		<idno type="ISSNe">1423-0046</idno>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="35" to="41" />
			<date type="published" when="1997" />
			<publisher>S. Karger AG</publisher>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Suppression of Cell Proliferation and Induction of Apoptosis in Uterine Leiomyoma by Gonadotropin-Releasing Hormone Agonist (Leuprolide Acetate)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Mizutani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Sugihara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Nakamuro</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Terada</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.83.4.1253</idno>
		<idno type="PMID">9543151</idno>
		<ptr type="open-access" target="https://academic.oup.com/jcem/article-pdf/83/4/1253/10442617/jcem1253.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Endocrinology &amp; Metabolism</title>
		<title level="j" type="abbrev">Journal of Clinical Endocrinology &amp; Metabolism</title>
		<idno type="ISSN">0021-972X</idno>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1253" to="1255" />
			<date type="published" when="1998-04-01" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Gonadotropin-releasing hormone analog repairs reduced endometrial cell apoptosis in endometriosis in vitro</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Atsushi</forename><surname>Imai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Atsushi</forename><surname>Takagi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Teruhiko</forename><surname>Tamaya</surname></persName>
		</author>
		<idno type="DOI">10.1067/mob.2000.104804</idno>
		<idno type="PMID">10819849</idno>
		<idno type="PII">S0002-9378(00)70176-1</idno>
		<idno type="ark">ark:/67375/6H6-XMQ8DL0G-3</idno>
		<idno type="istexId">E116B387C3F87AF8F2E3604B47D066BEEBC1B298</idno>
	</analytic>
	<monogr>
		<title level="j">American Journal of Obstetrics and Gynecology</title>
		<title level="j" type="abbrev">American Journal of Obstetrics and Gynecology</title>
		<idno type="ISSN">0002-9378</idno>
		<imprint>
			<biblScope unit="volume">182</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1142" to="1146" />
			<date type="published" when="2000-05" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
